Steve Yang

Co-CEO at WuXi AppTec

Steve Yang is a prominent figure in the pharmaceutical industry and currently serves as the Co-CEO of WuXi AppTec, a leading global provider of R&D and manufacturing services for the pharmaceutical, biotech, and medical device industries.1 2

Professional Background

Dr. Yang has an extensive career in pharmaceutical research and development:

He is currently Co-CEO and a board member of WuXi AppTec.1
At WuXi AppTec, he also heads the WuXi Biology and WuXi Testing businesses.1
Prior to joining WuXi AppTec, he held leadership positions at major pharmaceutical companies:
- Vice President and Head of Asia and Emerging Markets iMed at AstraZeneca.2 3
- Vice President and Head of Asia R&D at Pfizer.2 3
- Executive Director and head of Pfizer's global R&D strategic management group.2 3

Education and Expertise

Dr. Yang has a strong educational background in biological and pharmaceutical sciences:

Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco.1 2 3
BS in Biological Sciences (Summa Cum Laude) from Michigan Technological University.1
He began his undergraduate studies at Fudan University in China.1

Industry Recognition

Steve Yang is recognized in the pharmaceutical industry for his expertise in:

Building R&D and service capabilities.2 3
Delivering research and early development portfolios of drug candidates.2 3
Establishing R&D partnerships in the US, Europe, China, and other Asian and emerging markets.2 3

Additional Information

Dr. Yang is bilingual, with full professional proficiency in English and native or bilingual proficiency in Chinese.4
He co-founded the BayHelix Group, a non-profit global professional organization of Chinese life science business leaders, and served as the board's chairman for two terms.1